GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (NYSE:PM) » Definitions » YoY EBITDA Growth

Philip Morris International (Philip Morris International) YoY EBITDA Growth

: 2.09% (As of Dec. 2023)
View and export this data going back to 2008. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Philip Morris International's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 2.09%.

Philip Morris International's EBITDA per Share for the three months ended in Dec. 2023 was $2.15.


Philip Morris International YoY EBITDA Growth Historical Data

The historical data trend for Philip Morris International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philip Morris International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.11 8.71 10.24 -3.06 -0.84

Philip Morris International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -15.23 6.00 14.07 2.09

Philip Morris International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Philip Morris International's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(8.612-8.685)/ | 8.685 |
=-0.84 %

Philip Morris International's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(2.154-2.11)/ | 2.11 |
=2.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philip Morris International YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Philip Morris International's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Philip Morris International (Philip Morris International) Business Description

Address
677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Executives
Wilde Frederic De officer: Sr. VP, Marketing & Sales 120 PARK AVENUE, NEW YORK NY 10017
Yann Guerin officer: SVP & Global Head of L&C 677 WASHINGTON BLVD., SUITE 1100, STAMFORD CT 06901
Werner Barth officer: Sr. VP, Marketing and Sales 120 PARK AVENUE, NEW YORK NY 10017
Lars Dahlgren officer: Pres. Smoke-Free Oral Products 677 WASHINGTON BLVD., STAMFORD CT 06896
Dessislava Temperley director C/O CIMPRESS PLC, 275 WYMAN STREET, WALTHAM MA 02451
Reginaldo Dobrowolski officer: Vice President and Controller 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901
Martin G. King officer: SVP Operations 120 PARK AVENUE, NEW YORK NY 10017
Paul Riley officer: Pres East Asia & Australia 120 PARK AVENUE, NEW YORK NY 10017
Drago Azinovic officer: Pres., European Union Region 120 PARK AVENUE, NEW YORK NY 10017
Mario Masseroli officer: Pres., Latin America & Canada 120 PARK AVENUE, NEW YORK NY 10017
Juan J. Daboub director 5100 W. 115TH PLACE, LEAWOOD KS 66211
Shlomo Yanai director ONE MEADOWLANDS PLAZA, EAST RUTHERFORD NJ 07073
Stacey Kennedy officer: Pres. South & Southeast Asia 120 PARK AVENUE, NEW YORK NY 10017
Charles Bendotti officer: Senior VP, Human Resources 120 PARK AVENUE, NEW YORK NY 10017
Andre Calantzopoulos director, officer: President & CEO 677 WASHINGTON BLVD, SUITE 1100, STAMFORD CT 06901